|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$3,708||Benefits minus costs||$11,972|
|Participants||$0||Benefit to cost ratio||$10.12|
|Others||$8,380||Chance the program will produce|
|Indirect||$1,197||benefits greater than the costs||98 %|
|Net program cost||($1,312)|
|Benefits minus cost||$11,972|
|Detailed Monetary Benefit Estimates Per Participant|
|Benefits from changes to:1||Benefits to:|
|Adjustment for deadweight cost of program||$0||$0||$0||($654)||($654)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$1,289||2016||Present value of net program costs (in 2017 dollars)||($1,312)|
|Comparison costs||$0||2016||Cost range (+ or -)||10 %|
|Estimated Cumulative Net Benefits Over Time (Non-Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in non-discounted dollars to simplify the “break-even” point from a budgeting perspective. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
Daley M., Love C.T., Shepard D.S., Petersen C.B., White K.L., & Hall F.B. (2004). Cost-effectiveness of Connecticut's in-prison substance abuse treatment. Journal of Offender Rehabilitation, 39(3), 69-92.
Dugan J.R. and Everett, R.S. (1998). An experimental test of chemical dependency therapy for jail inmates. International Journal of Offender Therapy and Comparative Criminology, 42(4), 360-368.
Duwe, G. (2010). Prison-based chemical dependency treatment in Minnesota: An outcome evaluation. Journal of Experimental Criminology, 6(1), 57-81.
Hughey, R., & Klemke, L.W. (1996). Evaluation of a jail-based substance abuse treatment program. Federal Probation, 60(4), 40-45.
Porter, R. (2002). Breaking the cycle: Technical report. New York: Vera Institute of Justice.
Tunis, S., Austin, J., Morris, M., Hardyman, P., & Bolyard, M. (1996). Evaluation of drug treatment in local corrections (Document No. NCJ 159313). Washington, DC: National Institute of Justice.